Merz
axura.de – Informationen for professionals

Service

Product Characteristics and Product Monograph
Packshot Axura

Product Characteristics AXURA tablets

PDF-Dokument downloadenPDF
Packshot Axura

Product Characteristics AXURA solution

PDF-Dokument downloadenPDF
Wissenschaftliche Produktmonografie AXURA

Product Monograph AXURA

92 pages, 2004

PDF-Dokument downloadenPDF

Publications
Logo New England Journal of Medicine

Memantine in moderate-to-severe Alzheimer´s Disease

Reisberg et al. (2003). New England Journal of Medicine, 348 (14): 1333-41.
Abstract
Logo Geriatr. Psychiatry

Memantine in severe dementia: Results of the M-Best Study.

Winblad B. & Poritis, N. (1999). Psychiatry 14, 135 -146.
Abstract
Pharmacoeconomics

Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer's Disease.

Wimo A. et al. (2003). Pharmacoeconomics 21 (5), 327-340.
Abstract
Logo JAMA

Memantine treatment in patients with moderate to severe Alzheimer Disease already receiving Donepezil.

Tariot et al. (2004). JAMA 291, 317 -324
Abstract
International Clinical Psychopharmacology

Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.

Hartmann S. & Möbius HJ. (2003). International Clinical Psychopharmacology 18 (2), 81
Abstract

Slide Kit Service
Speaker's Kit

Clinical Studies of Memantine
View

©2004 Merz | Privacy Policy | Terms of Use | Imprint

Last update: 23 Jun 2004, 11:59 AM

produced by GPM mbH

If you can read this text, your browser browser does not the support the Web standard Cascading Style Sheets (C S S) for graphic display. We use C S S for page formatting, please don’t wonder if the pages display somewhat screwed lacking C S S.

axura.info. Service.
Retrieved 05 Aug 2004, 07:35 AM from Merz.com Web site: http://www.axura.info/service/

Copyright © 2004 Merz. All rights reserved.